Aeternum Health (AETN) Return on Capital Employed (2011 - 2026)

Aeternum Health (AETN) has 16 years of Return on Capital Employed data on file, last reported at 35.71% in Q1 2026.

• Return on Capital Employed for Q1 2026 came in at 35.71%, down 236.0% year-over-year; the trailing twelve-month figure through Mar 2026 was 35.71% (down 236.0% YoY), and the FY2025 annual result was 25.08%, down 3783.0% from the prior year.
• Return on Capital Employed grew to 35.71% in Q1 2026 per AETN's latest filing, from 25.18% in the prior quarter.
• Over five years, Return on Capital Employed peaked at 534.67% in Q4 2023 and troughed at 525.01% in Q3 2023.
• A 5-year average of 36.32% and a median of 25.18% in 2025 frame the typical range for Return on Capital Employed.
• On a YoY basis, Return on Capital Employed climbed as much as 65892 bps in 2023 and fell as far as 34883 bps in 2023.
• A 5-year view of Return on Capital Employed shows it stood at 124.25% in 2022, then jumped by 530 bps to 534.67% in 2023, then plunged by 89 bps to 56.44% in 2024, then sank by 55 bps to 25.18% in 2025, then soared by 42 bps to 35.71% in 2026.
• Business Quant data shows AETN's Return on Capital Employed at 35.71% in Q1 2026, 25.18% in Q4 2025, and 32.75% in Q3 2025.